Clinical Trials for Clementia Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Clementia Pharmaceuticals

Clinical Trials (1)

NCT05039515
A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).
PHASE2Active, not recruiting
113 participants
Started: Dec 1, 2021 · Completed: Mar 30, 2029
1 condition2 sponsors25 locations